Treatment with antipsychotics and the risk of diabetes in clinical practice

British Journal of Psychiatry

Volumn 197, Issue 4, 2010, Pages 266-271

  Kessing, Lars Vedel ^a   Thomsen, Anders Frøkjær ^a   Mogensen, Ulla Brasch ^b   Andersen, Per Kragh ^b  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; AMISULPRIDE; ANTIDIABETIC AGENT; ARIPIPRAZOLE; CLOZAPINE; GLIBENCLAMIDE; GLICLAZIDE; GLIMEPIRIDE; GLIPIZIDE; HALOPERIDOL; INSULIN; LITHIUM; METFORMIN; NEUROLEPTIC AGENT; OLANZAPINE; PERPHENAZINE; PIOGLITAZONE; QUETIAPINE; REPAGLINIDE; RISPERIDONE; ROSIGLITAZONE; SERTINDOLE; TOLBUTAMIDE; ZIPRASIDONE; ZUCLOPENTHIXOL;

ADULT; AGED; ARTICLE; CLINICAL PRACTICE; DENMARK; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYPHARMACY; PRESCRIPTION; RISK ASSESSMENT; RISK FACTOR; TREATMENT INDICATION;

ADULT; AGED; ANTIPSYCHOTIC AGENTS; BLOOD GLUCOSE; DENMARK; DIABETES MELLITUS; DRUG PRESCRIPTIONS; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; PHARMACOEPIDEMIOLOGY; POLYPHARMACY; SEX DISTRIBUTION; YOUNG ADULT;

EID: 77957681401     PISSN: 00071250     EISSN: 14721465     Source Type: Journal    
DOI: 10.1192/bjp.bp.109.076935     Document Type: Article

References (31)

1. Domino ME, Swartz MS. Who are the new users of antipsychotic medications? Psychiatr Serv 2008; 59: 507-14.
2. Dabelea D. The accelerating epidemic of childhood diabetes. Lancet 2009; 373: 1999-2000.
3. Mukherjee S, Decina P, Bocola V, Saraceni F, Scapicchio PL. Diabetes mellitus in schizophrenic patients. Compr Psychiatry 1996; 37: 68-73.
4. Dixon L, Weiden P, Delahanty J, Goldberg R, Postrado L, Lucksted A, et al. Prevalence and correlates of diabetes in national schizophrenia samples. Schizophr Bull 2000; 26: 903-12.
5. Regenold WT, Thapar RK, Marano C, Gavirneni S, Kondapavuluru PV. Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent of psychotropic drug use. J Affect Disord 2002; 70: 19-26. (Pubitemid 34756609)
6. Buse JB, Cavazzoni P, Hornbuckle K, Hutchins D, Breier A, Jovanovic L. A retrospective cohort study of diabetes mellitus and antipsychotic treatment in the United States. J Clin Epidemiol 2003; 56: 164-70. (Pubitemid 36315943)
7. Ramaswamy K, Masand PS, Nasrallah HA. Do certain atypical antipsychotics increase the risk of diabetes? A critical review of 17 pharmacoepidemiologic studies. Ann Clin Psychiatry 2006; 18: 183-94. (Pubitemid 44576440)
8. Smith M, Hopkins D, Peveler RC, Holt RIG, Woodward M, Ismail K. First- v. second-generation antipsychotics and risk for diabetes in schizophrenia: systematic review and meta-analysis. Br J Psychiatry 2008; 192: 406-11. (Pubitemid 351809892)
9. Saddichha S, Manjunatha N, Ameen S, Akhtar S. Diabetes and schizophrenia - effect of disease or drug? Results from a randomized, double-blind, controlled prospective study in first-episode schizophrenia. Acta Psychiatr Scand 2008; 117: 342-7. (Pubitemid 351502438)
10. Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 2005; 353: 1209-23.
11. Malig C. The Civil Registration System in Denmark. Technical Paper No 66. International Institute for Vital Registration and Statistics, 1996.
12. Danish National Board of Health, Lægemiddelstyrelsen. Medicinal Product Statistics. Lægemiddelstyrelsen, 2002 (http://www. laegemiddelstyrelsen.dk).
13. Juel K, Helweg-Larsen K. The Danish registers of causes of death. Dan Med Bull 1999; 46: 354-7.
14. Andersen TF, Madsen M, Jorgensen J, Mellemkjaer L, Olsen JH. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 1999; 46: 263-8.
15. Munk-Jorgensen P, Mortensen PB. The Danish Psychiatric Central Register. Dan Med Bull 1997; 44: 82-4.
16. WHO Collaborating Centre for Drug Statistics Methodology. ATC Index with DDDs. WHO Collaborating Centre for Drug Statistics Methodology, 2003.
17. World Health Organization. Glossary of Mental Disorders and Guide to their Classification for Use in Conjunction with the International Classification of Diseases, 8th Revision. WHO, 1974.
18. World Health Organization. International Statistical Classification of Diseases and Health Related Problems, 10th revision [Danish version]. Munksgaard, 1993.
19. Gianfrancesco FD, Grogg AL, Mahmoud RA, Wang RH, Nasrallah HA. Differential effects of risperidone, olanzapine, clozapine, and conventional antipsychotics on type 2 diabetes: findings from a large health plan database. J Clin Psychiatry 2002; 63: 920-30.
20. Gianfrancesco F, Grogg A, Mahmoud R, Wang RH, Meletiche D. Differential effects of antipsychotic agents on the risk of development of type 2 diabetes mellitus in patients with mood disorders. Clin Ther 2003; 25: 1150-71. (Pubitemid 36532584)
21. American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, North American Association for the Study of Obesity. Consensus development conference on antipsychotic drugs and obesity and diabetes. J Clin Psychiatry 2004; 65: 267-72.
22. Newcomer JW, Nasrallah HA, Loebel AD. The Atypical Antipsychotic Therapy and Metabolic Issues National Survey: practice patterns and knowledge of psychiatrists. J Clin Psychopharmacol 2004; 24: S1-6.
23. Yood MU, DeLorenze G, Quesenberry Jr CP, Oliveria SA, Tsai AL, Willey VJ, et al. The incidence of diabetes in atypical antipsychotic users differs according to agent-results from a multisite epidemiologic study. Pharmacoepidemiol Drug Saf 2009; 18: 791-9.
24. Kristensen JK. Identification of the Type 2 Diabetes Population in a Danish County and Evaluation of the Performed Care in a Five-Year Period. Aarhus Universitet, 2000.
25. Drivsholm TB, Frederiksen K, de Fine ON, Odegaard B, Kristensen JK. The prevalence of diabetes in Denmark. Development of a method for a registry-based assessment [in Danish]. Ugeskr Laeger 2003; 165: 2887-91.
26. Leslie DL, Rosenheck RA. Incidence of newly diagnosed diabetes attributable to atypical antipsychotic medications. Am J Psychiatry 2004; 161: 1709-11.
27. Jin H, Meyer JM, Jeste DV. Phenomenology of and risk factors for new-onset diabetes mellitus and diabetic ketoacidosis associated with atypical antipsychotics: an analysis of 45 published cases. Ann Clin Psychiatry 2002; 14: 59-64. (Pubitemid 34538833)
28. Centers for Disease Control and Prevention. National Diabetes Surveillance System. Centers for Disease Control and Prevention, 2009 (http://apps.nccd.cdc.gov/ddtstrs/).
29. Berger B, Stenstrom G, Sundkvist G. Incidence, prevalence, and mortality of diabetes in a large population. A report from the Skaraborg Diabetes Registry. Diabetes Care 1999; 22: 773-8.
30. Ryan R, Newnham A, Khunti K, Majeed A. New cases of diabetes mellitus in England and Wales, 1994-1998: database study. Public Health 2005; 119: 892-9.
31. Garancini MP, Gobbi C, Errera A, Sergi A, Gallus G. Age-specific incidence and duration of known diabetes. The Cremona Study. Diabetes Care 1996; 19: 1279-82.